Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
LCP2 and hepatocellular carcinoma are reported together in 1 article.
Gene
LCP2
- HGNC
- HGNC:6529
2articles
2mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
Phenotype
Hepatocellular carcinoma
417articles
417mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
1 records shown · first 60Effect of MHC Linked 7-Gene Signature on Delayed Hepatocellular Carcinoma Recurrence.
PMID 34834481 | PMCID PMC8625636 | DOI 10.3390/jpm11111129 · Journal of personalized medicine · 2021 · 11 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | LCP2 | “A set of seven genes (NCF4, TYROBP, LCP2, ZAP70, PTPRC, FYN and WAS) was found co-expressed at gene-gene interaction level in both cohorts.” | 0.98 | hgnc_dict_v1 |
| phenotype | hepatocellular carcinoma | “Effect of MHC Linked 7-Gene Signature on Delayed Hepatocellular Carcinoma Recurrence.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | HLA-DMA | “HLAs including HLA-DMA, HLA-DMB, HLA-DOA and HLA-DRB6 were associated with delayed recurrence in both discovery (204 HCC cases) and validation (372 HCC cases) cohorts.” | 0.98 | hgnc_dict_v1 |
| gene | HLA-DMB | “HLAs including HLA-DMA, HLA-DMB, HLA-DOA and HLA-DRB6 were associated with delayed recurrence in both discovery (204 HCC cases) and validation (372 HCC cases) cohorts.” | 0.98 | hgnc_dict_v1 |